ORIC Pharmaceuticals, Inc.

Direct answer

ORIC Pharmaceuticals, Inc. is publicly traded on NASDAQ under the ticker ORIC.

ORIC Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical firm dedicated to discovering and advancing innovative treatments for cancer patients across the United States. The company's pipeline includes several key clinical-stage drug candidates. ORIC-533 is an oral small molecule designed to inhibit CD73, addressing resistance to both chemotherapy and immunotherapy. Another candidate, ORIC-944, is an...

Can you invest in ORIC Pharmaceuticals, Inc.?

Yes. ORIC Pharmaceuticals, Inc. trades publicly on NASDAQ as ORIC.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for ORIC Pharmaceuticals, Inc.

Detailed equity research is provided by MarketSnap.